CHRISTINA PERKINS: Open Payments
NPI 1265924807 · FLOWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,821 in 231 payments from 21 companies in 2025. Trend: 2023 $3,085 · 2024 $3,296 · 2025 $3,821
Food & beverage: $3,773Education: $48
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $485 |
| UCB, Inc. | 32 | $469 |
| Novartis Pharmaceuticals Corporation | 20 | $430 |
| Janssen Biotech, Inc. | 13 | $336 |
| Mallinckrodt Hospital Products Inc. | 14 | $320 |
| Galderma Laboratories, L.P. | 19 | $221 |
| PFIZER INC. | 10 | $210 |
| GENZYME CORPORATION | 5 | $197 |
| Arcutis Biotherapeutics, Inc. | 16 | $154 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $150 |
Products named: Bimzelx, SKYRIZI, DUPIXENT, TREMFYA, ACTHAR, NEMLUVIO, COSENTYX, Zoryve.
Industry payments across MS — which companies pay providers there.
